XML 53 R40.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-based compensation plans (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Activity related to restricted stock units The activity related to restricted stock units for the year ended December 31, 2021 is as follows:
NonvestedVested
Total
Average Grant
Date Fair
Value Per Share
Outstanding, December 31, 2020209,583 75,863 285,446 $50.19 
   Granted201,570 — 201,570 $57.77 
   Vested(68,231)68,231 — 
   Converted— (64,093)(64,093)$53.28 
   Cancelled(12,053)— (12,053)$55.98 
   Dividend equivalents1,728 2,263 3,991 $62.95 
Outstanding, December 31, 2021332,597 82,264 414,861 $53.32 
Activity related to performance contingent restricted stock units The activity related to performance contingent restricted stock units for the year ended December 31, 2021 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value per Share
Outstanding, December 31, 2020157,122 166,432 323,554 $49.15
   Granted145,696 — 145,696 $55.95
   Performance adjustments256,711 — 256,711 $54.28
   Vested(64,243)64,243 — 
   Converted— (133,960)(133,960)$46.34
   Cancelled(14,633)— (14,633)$54.79
   Dividend equivalents— 938 938 $62.95
Outstanding, December 31, 2021480,653 97,653 578,306 $53.67
Estimated fair values of all SARs applying assumptions The Company computed the estimated fair values of all SARs granted during 2019 using the Black-Scholes option-pricing model applying the assumptions set forth in the following table:
2019
Expected dividend yield2.7 %
Expected stock price volatility16.6 %
Risk-free interest rate2.6 %
Expected life of SARs6 years
Company's SARs
The activity related to the Company’s SARs for the year ended December 31, 2021 is as follows: 
NonvestedVestedTotal
Weighted-
average
Exercise
Price
Outstanding, December 31, 2020397,677 873,751 1,271,428 $53.83 
   Vested(259,687)259,687 — 
   Granted— — — $— 
   Exercised— (363,102)(363,102)$50.95 
   Forfeited/Expired(13,826)(14,829)(28,655)$53.12 
Outstanding, December 31, 2021124,164 755,507 879,671 $55.03 
Exercisable, December 31, 2021— 755,507 755,507 $54.08 
Schedule of other share-based compensation, activity The activity related to deferred compensation for equity award units granted to both employees and non-employee directors combined is as follows:
Total
Outstanding, December 31, 2020372,413 
   Deferred38,127 
   Converted(40,527)
   Dividend equivalents10,744 
Outstanding, December 31, 2021380,757